Wednesday 6-25-2014 Ariad Pharmaceuticals (ARIA) $ARIA

New Post Public Reply Private Reply Replies (0) Message Board

Jun 25, 2014 at 8:18 PM

Wednesday 6-25-2014 Ariad Pharmaceuticals (ARIA) $ARIA opened at 6.31 hitting the high price of 6.43 and a day low of 6.26 with a total volume of 5,275,644. ARIA had a previous close of 6.31 and has been seeing an average volume of 7,969,280.

Overall Average: 72% Sell

Recent stock forum discussions about ARIA http://investorshangout.com/search?q=ARIA&...mp;yt0=Go!

Ariad Pharmaceuticals Up 72.2% Since SmarTrend Uptrend Call (ARIA)
Comtex SmarTrend(R) - Wed Jun 25, 9:08AM CDT
SmarTrend identified an Uptrend for Ariad Pharmaceuticals (NASDAQ:ARIA) on November 22nd, 2013 at $3.67. In approximately 7 months, Ariad Pharmaceuticals has returned 72.21% as of today's recent price of $6.32. (full story)

Merck KGaA-Mersana Therapeutics Strike a Deal on ADCs - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jun 24, 4:20PM CDT
Merck KGaA (MKGAF) inked a deal with Mersana Therapeutics for the development of next-generation antibody-drug conjugates (ADCs) for the treatment of cancer. (full story)

Ohr Pharmaceutical (OHRP) Soars: Stock Adds 16.9% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jun 24, 8:18AM CDT
Ohr Pharmaceutical, Inc. (OHRP) was a big mover last session, as the company saw its shares rise by almost 17% on the day. (full story)

Weakness Seen in Alcobra (ADHD): Stock Falls 6.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jun 24, 7:35AM CDT
Alcobra stock fell nearly 7% last trading session, reversing its recent uptrend (full story)

Cardiome Pharma (CRME) Jumps: Stock Gains 7.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jun 23, 8:46AM CDT
Cardiome Pharma (CRME) was a big mover last session, with shares rising over 7% on the day. (full story)

Genocea Biosciences (GNCA) Jumps: Stock Rises 8.7% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jun 23, 8:39AM CDT
Genocea Biosciences, Inc. (GNCA) was a big mover last session, as its shares rose nearly 9% on the day. (full story)

Heron Therapeutics (HRTX) in Focus: Stock Gains 7.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jun 23, 8:25AM CDT
Heron Therapeutics (HRTX) was a big mover last session, with shares rising over 7% on the day. (full story)

Weakness Seen in Cerulean Pharma (CERU): Stock Slumps 20.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jun 23, 7:57AM CDT
Cerulean Pharma has seen negative earnings estimate revision for the current quarter along with a significant decline in its share price for the last day (full story)

Flamel Technologies (FLML) Jumps: Stock Adds 18.8% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jun 23, 7:51AM CDT
Flamel Technologies SA (FLML) was a big mover last session, as its shares rose nearly 19% on the day. (full story)

ARIAD Announces Three Key Appointments to Its Global Management Team
Business Wire - Mon Jun 23, 6:35AM CDT
ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) today announced the recent appointments of three executives with extensive pharmaceutical industry experience in the areas of global quality, medical affairs, and drug safety and pharmacovigilance. (full story)

FDA Drops the Hammer on Twitter
David Williamson and Michael Douglass, The Motley Fool - Motley Fool - Sun Jun 22, 4:30PM CDT
The FDA just announced new regulations for pharma and biotech companies that wish to promote their drugs via Twitter (Nasdaq: TWTR). Companies cannot brag about a drugs benefits without also tweeting about the associated risks of taking it. There... (full story)

Tetraphase Progresses with Eravacycline Late-Stage Study - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 20, 4:20PM CDT
Tetraphase Pharmaceuticals (TTPH) announced the completion of patient enrolment for the phase III IGNITE 2 study on eravacycline. (full story)

Aerie Pharmaceuticals (AERI) in Focus: Stock Moves 6.8% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jun 20, 8:18AM CDT
Aerie Pharmaceuticals, Inc. (AERI) was a big mover last session, as the company saw its shares rise by almost 7% on the day. (full story)

BioLineRx to Commence BL-8040 Study - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jun 19, 5:10PM CDT
BioLineRx Ltd. (BLRX) announced that the Israeli Ministry of Health informed the company that it can start a phase I study on its oncology candidate, BL-8040. (full story)

Endocyte (ECYT) in Focus: Stock Tanks 14% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jun 19, 7:56AM CDT
Endocyte, Inc. (ECYT) saw a big move last session,reversing the most recent trend for ECYT as the stock is now up around 7.6% since June 3, 2014 (full story)

Receptos (RCPT) in Focus: Stock Up 6.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jun 19, 7:51AM CDT
Receptos, Inc. (RCPT) was a big mover last session, as its shares rose nearly 7% on the day. (full story)

Flexion Therapeutics, Inc. (FLXN) Soars: Stock Adds 15.7% in Session - Tale of the Tape
Abhijit Ghosh - Zacks Investment Research - Thu Jun 19, 7:30AM CDT
Flexion Therapeutics, Inc. (FLXN) was a big mover last session, as its shares rose nearly 16% on the day. (full story)

Merck KGaA-Ono Pharma Deal Ends - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jun 18, 5:15PM CDT
Merck KGaA (MKGAF) has decided to terminate its license agreement with Ono Pharma related to the development of Ono Pharma's multiple sclerosis candidate, ceralifimod (ONO-4641). (full story)

Merck Backs Out of Endocyte Vintafolide Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jun 18, 11:10AM CDT
Endocyte, Inc. (ECYT) announced that it has regained worldwide rights to oncology candidate, vintafolide, as Merck decided to discontinue its investment in the development of vintafolide. (full story)

Portola Pharmaceuticals, Inc. (PTLA) in Focus Stock Up 5.72% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jun 18, 7:44AM CDT
Portola Pharmaceuticals, Inc. (PTLA) was a big mover last session, as the company saw its shares gain nearly 6% on the day. (full story)

ARIAD Pharmaceuticals Inc. (ARIA) Stock Research Links

ARIA Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

First Student Reduces Collisions by 63% with HALO Tech

Making Every School Bus Ride Safer Here's some good news in the world of transportation, especially if you're keen on keeping kids safe on the daily school bus run. First Student's HALO™ Connected Transportation Platform claims it made a significant dent in reducing accidents—specifically, a 63% cut in forward collision risk. It's a big promise when you're talking...

Understanding Truck Accident Settlements in Memphis

Delving into Truck Accident Settlement Timelines Out there in Memphis, timing a truck accident settlement isn't exactly like clockwork work. When it comes to getting your compensation, the timeline varies as widely as a duck hunting trip—sometimes you come home with a basketful, sometimes it’s empty. It might be a quick couple of months or drag on past a year, and...

Malachi Joe's Memoir Reveals an Untouched History

A Memoir of Profound Historical Reflection Picture a life that starts on forty acres in segregated rural South Carolina. Throw in two tours in Vietnam and several decades of living between these chapters. This isn't some fictional saga; it's the heartbeat of Malachi Joe's new memoir, A Letter from Your Father. Released by Palmetto Publishing, we're looking at a story that...

AEP Boosts Dividend Amid $78 Billion Expansion Plan

Dividend Hike Sets the Stage Kicking things off with a neat little surprise, American Electric Power (NASDAQ:AEP) has decided to fatten up that dividend check to 97 cents per share—or a solid 2-cent bump. Now, that might not have you dancing on the trading floor, but it sure shows us that AEP's got intentions worth watching. We're looking at a December 10 payday, so...

Taiwan Excellence Sparks Smart Automotive Innovation at SEMA

Taiwan's making waves, folks, and it's not your everyday splash in the automotive pool. At SEMA 2026, Taiwan Excellence Pavilion is the place to be with its array of intelligent automotive solutions. This ain't just your run-of-the-mill car show gimmickry—it's the future rolling in real-time. Driving Innovation: From Components to Smart Systems The name of the game is...

CATL's Dual-Electric Battery Will Boost Trucking

CATL's Game-Changer in Heavy-Duty Truck Batteries When CATL unveils something new, it's like dropping a sledgehammer on a penny—a big impact that makes you wonder what took so long, and here they are rolling out their dual-electric range extension battery. Tackling two birds with one stone, they're pushing electric heavy-duty trucks into a whole new gear. This isn't...

ITG Names Juliette Aiken CMO to Boost Storyteq's Reach

How do you put the throttle down on AI-driven content in a market that’s gasping for more? You bring in a heavyweight. Storyteq, the brainchild platform of Inspired Thinking Group (ITG), has roped in Juliette Aiken as their new Chief Marketing Officer. A veteran of the field, Juliette is tasked with propelling Storyteq from strong performer to an unbeatable force. New...

Ford Foundation Welcomes Gender Justice Leader Fatima Goss Graves

A Fresh Addition to Ford's Trustees Fatima Goss Graves steps into big shoes at the Ford Foundation as she gets appointed to its Board of Trustees. No small potatoes, this move suggests the Foundation's commitment to driving significant gender justice and advocacy. Add her name next to serious change-makers, folks, because Ms. Goss Graves is a heavyweight in the nonprofit...

AHN Opens Clinic for Severe Postpartum Tear Care

A Game Changer for Postpartum Recovery When it comes to childbirth, you think you've heard it all, but here's a twist—Allegheny Health Network (AHN) just swung the doors open on a clinic laser-focused on a very raw deal: third- and fourth-degree perineal lacerations. We're diving into new territory where one network sees the gap and jumps into action, calling in the...

University of Phoenix Lowers Costs for Transfer Students

The Pocket-Saving Game of Transfer Credits Here's the buzz: the University of Phoenix is putting some serious coin back into students' pockets through transfer credits. We're looking at more than $12,010 in savings per student, thanks to these policies, which is no chump change by any stretch. As over 900,000 credits were tossed into the pot, the savings side of education...